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ABSTRACT Palladin is an important component of motile actin-rich structures and
nucleates branched actin ﬁlament arrays in vitro. Here we examine the role of palla-
din during Listeria monocytogenes infections in order to tease out novel functions of
palladin. We show that palladin is co-opted by L. monocytogenes during its cellular
entry and intracellular motility. Depletion of palladin resulted in shorter and mis-
shapen comet tails, and when actin- or VASP-binding mutants of palladin were over-
expressed in cells, comet tails disintegrated or became thinner. Comet tail thinning
resulted in parallel actin bundles within the structures. To determine whether palla-
din could compensate for the Arp2/3 complex, we overexpressed palladin in cells
treated with the Arp2/3 inhibitor CK-666. In treated cells, bacterial motility could be
initiated and maintained when levels of palladin were increased. To conﬁrm these
ﬁndings, we utilized a cell line depleted of multiple Arp2/3 complex subunits. Within
these cells, L. monocytogenes failed to generate comet tails. When palladin was over-
expressed in this Arp2/3 functionally null cell line, the ability of L. monocytogenes to
generate comet tails was restored. Using puriﬁed protein components, we demon-
strate that L. monocytogenes actin clouds and comet tails can be generated (in a
cell-free system) by palladin in the absence of the Arp2/3 complex. Collectively, our
results demonstrate that palladin can functionally replace the Arp2/3 complex dur-
ing bacterial actin-based motility.
IMPORTANCE Structures containing branched actin ﬁlaments require the Arp2/3
complex. One of the most commonly used systems to study intracellular movement
generated by Arp2/3-based actin motility exploits actin-rich comet tails made by Lis-
teria. Using these infections together with live imaging and cell-free protein reconsti-
tution experiments, we show that another protein, palladin, can be used in place of
Arp2/3 to form actin-rich structures. Additionally, we show that palladin is needed
for the structural integrity of comet tails as its depletion or mutation of critical re-
gions causes dramatic changes to comet tail organization. These ﬁndings are the
ﬁrst to identify a protein that can functionally replace the Arp2/3 complex and have
implications for all actin-based structures thought to exclusively use that complex.
KEYWORDS actin nucleation, actin polymerization, Listeria monocytogenes
The infectious cycle of the invasive and motile bacterium Listeria monocytogenesrelies heavily on its ability to exploit the epithelial cell actin cytoskeleton. These
bacteria require actin ﬁlaments for their uptake into epithelial cells (1) and for their
formation of motile actin-rich structures generated within their host cells called
comet tails (2, 3). During comet tail formation, L. monocytogenes recruits and
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activates the Arp2/3 complex to one of their poles through the N-WASP-mimick-
ing bacterial protein ActA (4). This recruitment stimulates the force-generating,
branched actin polymerization that is needed to propel L. monocytogenes within
and among host cells and functions at the molecular level, similarly to lamellipodia
in migrating eukaryotic cells (5).
The actin-binding protein palladin is widely expressed in developing and adult
vertebrate cells and tissues (6–8). This multifunctional protein acts as a scaffolding
protein by recruiting other actin-related proteins, such as proﬁlin (9), VASP (10),
-actinin (11), ezrin (7), PDLIM1 (12), Eps8 (13), and LASP-1 (8), to actin-rich structures
within the cell. Palladin can directly cross-link actin ﬁlaments, an activity that has been
linked to its Ig3 domain (14), and can generate cross-linked actin ﬁlaments when pure
preparations of palladin and monomeric actin are coincubated in vitro (15). In this
study, we explore the involvement of palladin during L. monocytogenes infections and
simultaneously use L. monocytogenes infections as a model to study the functional roles
of palladin.
RESULTS
Palladin localizes to L. monocytogenes entry sites and actin-rich comet tails,
but not listeriopods. L. monocytogenes exploits the actin polymerization machinery at
four distinct times: (i) for entry into cells, (ii) as a cloud of F-actin surrounds immotile
bacteria, (iii) for intracellular motility, and (iv) for cell-to-cell spreading. When these
microbes hijack the actin cytoskeleton, they rearrange it into dynamic morphological
structures (actin clouds, comet tails, and listeriopods). To determine if palladin was
recruited to these structures, we infected HeLa cells with wild-type L. monocytogenes
and stained ﬁxed cells for endogenous palladin. We found that palladin was recruited
to bacterial entry sites, actin clouds, and comet tails, but was absent from listeriopods
(Fig. 1A). The altered localization of palladin in infected cells did not change its level of
expression (see Fig. S1 at https://ﬁgshare.com/s/ded44d01de3f33a00800).
Because these bacterially induced actin-based structures are highly dynamic, we
sought to determine the recruitment characteristics of palladin in relation to actin. To
do this, we cotransfected Ptk2 cells with green ﬂuorescent protein (GFP)-palladin and
mKate-LifeAct and saw their simultaneous recruitment to actin clouds surrounding
stationary bacteria as well as at motile comet tails (see Movie S1 in the supplemental
material). When comet tails pushed motile bacteria into the plasma membrane to
initiate listeriopod formation, overall palladin intensity decreased to general cytoplas-
mic levels, except at regions close to the bacterium-actin interface that continued to
show increased palladin recruitment (see Movie S2 in the supplemental material).
Palladin is required for the proper formation and motility of comet tails. To
investigate the importance of palladin during comet tail formation, we depleted
palladin in HeLa cells using small interfering RNA (siRNA) and then infected the cells
with L. monocytogenes (Fig. 1B and E). We found no signiﬁcant effects on bacterial
invasion in cells with undetectable levels of palladin compared to control siRNA-treated
cells (see Fig. S2A at https://ﬁgshare.com/s/f122734e94f779c319fa). Because bacteria
could still invade host cells, we examined the morphology of comet tails in palladin-
depleted cells and discovered that comet tails were signiﬁcantly shorter than those in
control siRNA-treated cells (Fig. 1C). Actin staining also showed that in palladin-
depleted cells, comet tails were distorted compared to their straighter counterparts in
control cells (Fig. 1E and F). We quantiﬁed this difference by measuring the ratio of the
full comet tail length to the shortest distance between the bacterium-tail interface and
the end of the comet tail (tortuosity index) and conﬁrmed that comet tails in palladin-
depleted cells were severely tortuous (Fig. 1D), further supporting palladin’s role within
the eukaryotic cytoskeleton as an important actin-cross-linking protein. Interestingly,
listeriopods appeared unaltered in the absence of palladin (see Fig. S2B at https://
ﬁgshare.com/s/f122734e94f779c319fa).
Palladin mutations dramatically alter L. monocytogenes motility and F-actin
organization within comet tails. The actin and VASP binding domains of palladin are
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FIG 1 Palladin is hijacked by L. monocytogenes in order to maintain the structural integrity of actin-rich comet tails. (A)
HeLa cells were infected with wild-type L. monocytogenes (Lm) for 30 min (invasion) or 6 h (comet tail and listeriopod
formation), ﬁxed, and stained with a mouse palladin-targeting monoclonal antibody (green), DAPI (blue) to visualize DNA,
and Alexa 594-phalloidin (red) to visualize actin. Palladin is recruited to bacterial invasion sites’ actin clouds, and comet tails
but not listeriopods (boxed regions). Open arrowheads within insets (enlargement of boxed regions) indicate individual
bacteria, while solid arrowheads point to the actin clouds, comet tails, and listeriopods of interest. Scale bars, 10 m and
2 m (insets). (B) HeLa cells were treated with nontargeting control (Ctrl) or palladin-targeted (knockdown [KD]) siRNA
sequences, and whole-cell lysates were collected and probed for endogenous palladin using a rabbit polyclonal anti-
palladin antibody. The black arrowhead indicates palladin isoform 4; additional bands show other palladin isoforms.
Calnexin is shown as a loading control. (C and D) Average comet tail length (C) and tortuosity (D) in control (Ctrl) and
palladin-targeted (KD) siRNA-treated cells. The average comet tail lengths were as follows: 5.172 m in control cells and
2.646 m in knockdown cells. The average comet tail tortuosities (indicated by tortuosity index) were as follows: 1.150 in
control cells and 1.343 in knockdown cells. Asterisks indicate P  0.0001 in panel C and P  0.01 in panel D. (E) HeLa cells
were treated with nontargeting control or palladin-targeted siRNA sequences and infected with wild type L. monocyto-
genes for 6 h. Cells were ﬁxed and stained with a mouse anti-palladin monoclonal antibody (green), DAPI (blue) to visualize
(Continued on next page)
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important for its normal functioning (16, 17). We examined the inﬂuence of those
regions on L. monocytogenes infections by overexpressing palladin domain mutants
that acted in dominant-negative fashions (Fig. 2A).
The actin binding ability of palladin has been tied to three key lysine residues (K15,
K18, and K51) within its C-terminally located Ig3 domain (Fig. 2A). When a palladin
variant mutated at these residues (palladinK15/18/51A) is expressed in cells, abnormal
nuclear localization of palladin and extensive cytoskeletal perturbations in cultured
epithelial cells are evident (16). We cotransfected GFP-palladinK15/18/51A (actin-
binding mutant) with mKate-LifeAct into HeLa cells and viewed, via time-lapse imaging,
motile bacteria during L. monocytogenes infections. We used the known nuclear
localization of GFP-palladinK15/18/51A as a readout of cells that had functionally
perturbed palladin and found that motile comet tails disintegrated at their distal ends,
leaving behind a trail of comet tail debris (Fig. 2B; see Movie S3 in the supplemental
material). The crumbling comet tails moved at rates approximately 2-fold slower than
comet tails in cells overexpressing GFP-tagged wild-type palladin (Fig. 2C).
The actin-associated protein VASP classically localizes to the surface of L. monocy-
togenes through direct interactions with the bacterial protein ActA; however, it is also
present throughout the comet tail (Fig. 2D). To assess the requirement of ActA
expression on palladin recruitment to the bacterial surface, we utilized bacteria with
actA deletion. Not surprisingly, palladin was unable to be redistributed to the surface
of these mutant bacteria (see Fig. S3 at https://ﬁgshare.com/s/60c87e090bce18cad3ba).
Due to the importance of VASP during L. monocytogenes motility (18–21) and its
association with palladin at actin-rich structures within the cell (17), we examined the
functional role of palladin-VASP interactions during L. monocytogenes infections by
using a GFP-tagged palladin construct mutated in its VASP-binding polyproline motif
(GFP-palladinFPAA). We found dramatic alterations to the actin cytoskeleton in GFP-
palladinFPAA-expressing cells. In these cells, abnormal cytoplasmic clumps and bar-like
structures were generated that were enriched with actin and VASP (see Fig. S4A and B
at https://ﬁgshare.com/s/709e87fc36ce62e52548). We could not identify these unusual
structures in either GFP-palladin- or GFP-palladinK15/18/51A-expressing cells (see
Fig. S4A). We used these abnormal actin-rich formations together with GFP as conve-
nient markers for cells that were successfully transfected with GFP-palladinFPAA. When
actin clouds were examined during live infections, the ﬁlamentous actin appeared
notably diffuse around nonmotile bacteria (Fig. 2B; see Movie S4 in the supplemental
material). Strikingly, when comet tails were viewed, they became progressively thinner
as they moved (Fig. 2B; Movie S4). The thin comet tails also remained tethered to
remnants of diffuse actin clouds that had stayed behind in their original location
surrounding the L. monocytogenes bacteria prior to their launch into dynamic
motility (Fig. 2B; Movie S4). We also found that endogenous VASP was redistributed
away from comet tails in GFP-palladinFPAA-expressing cells; however, its recruit-
ment to the surface of bacteria remained unaltered (Fig. 2D). Motility rates of
bacteria in GFP-palladinFPAA-expressing cells decreased by 4-fold compared to
GFP-palladin-overexpressing cells (Fig. 2C).
To gain further insight into the thinning events occurring at comet tails, we used
transmission electron microscopy. Comet tails normally exploit the Arp2/3 complex to
generate a branched actin ﬁlament network. We found that the arrangement of F-actin
throughout the thinned GFP-palladinFPAA comet tails contained parallel arrays of
F-actin, whereas mock-transfected and GFP-palladin-transfected cells did not (Fig. 2E to
G). Collectively, these ﬁndings show that the actin-binding and scaffolding roles of
FIG 1 Legend (Continued)
DNA, and Alexa 594-phalloidin (red) to visualize actin. Comet tails are shorter and severely tortuous in palladin-depleted
cells (boxed regions). Scale bar, 5 m. (F) Enlargement of boxed regions from panel E. Open arrowheads indicate individual
bacteria, while solid arrowheads point to comet tails. Note the color levels were modiﬁed from panel E to enhance bacteria
and comet tails. Scale bar, 1 m.
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FIG 2 Palladin mutations dramatically alter L. monocytogenes motility rates and F-actin organization within actin-rich
comet tails. (A) Schematic diagram of palladin showing the FPAA (purple arrowhead) and K15/18/51A (yellow arrowheads)
mutation sites. The proline-rich region (PR) and immunoglobulin-like (Ig) domains are indicated. (B) Still frames from
movies of HeLa cells cotransfected with mKate-LifeAct to visualize actin and one of the GFP-tagged wild-type palladin,
palladinK15/18/51A, or palladinFPAA DNA constructs and infected with wild-type L. monocytogenes for at least 6 h. Comet
tails disintegrate into clumps in GFP-palladinK15/18/51A-expressing cells or become progressively thinner in GFP-
palladinFPAA-expressing cells (boxed regions). Open arrowheads within insets (enlargement of boxed regions) indicate
individual bacteria, while solid arrowheads point to a normal comet tail (palladin) or broken comet tail clumps (palla-
dinK15/18/51A). The double-headed arrow indicates a thin comet tail (palladinFPAA) tethered to its diffuse actin cloud
(white star). Note the inset color levels were modiﬁed to enhance comet tails. Scale bars, 5 m and 1 m (insets). (C) Mean
rates of intracellular movement of wild-type L. monocytogenes. The average bacterial speeds were as follows: 7.117 m/min
(Continued on next page)
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palladin are crucial for the proper formation and organization of branched actin
ﬁlament arrays within comet tails.
Palladin compensates for the Arp2/3 complex during L. monocytogenes actin-
based motility. We have recently shown that palladin can generate actin ﬁlaments in
vitro (15). Based on these ﬁndings, we investigated whether palladin’s apparent actin-
nucleating ability could be exploited by L. monocytogenes to maintain its motility if the
Arp2/3 complex was functionally defective. To do this, we examined the motility of
L. monocytogenes in cells overexpressing GFP-palladin, GFP-palladinK15/18/51A, or
GFP-palladinFPAA prior to (and following) perfusion of the Arp2/3 complex inhibitor
CK-666 (22). A cessation of L. monocytogenes motility has already been demonstrated
in infected cells treated with CK-666 (22). We conﬁrmed this by live-cell imaging of
L. monocytogenes infections of cells with endogenous levels of palladin and noticed an
immediate disassembly of actin clouds and comet tails resulting in immotile bacteria
when CK-666 was introduced (Fig. 3A; see Movie S5 in the supplemental material).
Remarkably, when GFP-palladin was overexpressed in cells, L. monocytogenes comet
tails remained motile throughout treatment with CK-666 (Fig. 3A; see Movie S6 in the
supplemental material). Additionally, bacteria with actin clouds that were stationary
prior to the addition of CK-666 in GFP-palladin-overexpressing cells were still able to
generate comet tails and became motile in a manner indistinguishable from bacteria in
untreated cells, suggesting that exogenous palladin is not functioning solely as a
stabilizer of preexisting comet tails during treatment with CK-666 (see Movie S7 in the
supplemental material). Bacterial motility was also evident in cells overexpressing
GFP-palladinK15/18/51A or GFP-palladinFPAA (actin- or VASP-binding palladin mu-
tants) after CK-666 was introduced (Fig. 3A; see Movies S8 and S9 in the supplemental
material), albeit with the crumbling and thinning comet tail phenotypes described
earlier.
To gain further insight into this novel function of palladin, we tracked the speed of
motile bacteria by time-lapse microscopy (Fig. 3B). Before the addition of CK-666,
motile L. monocytogenes bacteria in cells with endogenous amounts of palladin moved
at an average speed of 8.990 m/min (Fig. 3C). Following CK-666 treatment, bacterial
speeds dropped signiﬁcantly to an average of 0.279 m/min (Fig. 3C). Although the
majority of motile bacteria came to a complete stop after the introduction of CK-666,
a fraction of the bacteria displayed a slow (1.281 m/min), jerky movement (Fig. 3B).
Interestingly, L. monocytogenes motility rates in CK-666-treated cells overexpressing
GFP-tagged wild-type palladin were unaltered upon treatment with CK-666 and dis-
played speeds similar to those of bacteria in wild-type cells prior to the drug treatment
(Fig. 3B and C).
To further characterize this novel function of palladin, we set out to examine
bacterial actin-based motility in cells depleted of the Arp2/3 complex. To do this, we
utilized a recently established Arpc2 conditional knockout cell line (23). In these cells,
loss of the Arpc2 gene product (p34) also caused the depletion of additional Arp2/3
complex subunits, including Arp2 and Arp3 (23). A challenge in studying L. monocyto-
genes infections in Arpc2/ cells was that the bacteria could not invade the cells. To
overcome this, we preinfected wild-type cells with L. monocytogenes and then mixed
the infected wild-type cells with Arpc2/ cells expressing GFP-palladin or the GFP
FIG 2 Legend (Continued)
in palladin-expressing cells, 2.983 m/min in palladinK15/18/51A-expressing cells, and 1.635 m/min in palladinFPAA-
expressing cells. *, P 0.01. (D) Endogenous VASP localizes to the bacterial surface and comet tail but is absent from comet
tails in palladinFPAA-expressing cells. HeLa cells transfected with palladinFPAA and infected with wild-type L. monocyto-
genes for 6 h were ﬁxed and stained with a rabbit polyclonal VASP-targeting antibody (green) and Alexa 594-phalloidin
(red) to visualize actin. Open arrowheads indicate individual bacteria, while solid arrowheads point to the comet tails of
interest. Scale bar, 1 m. (E to G) Electron micrographs of wild-type L. monocytogenes comet tails in mock-transfected (E
and E=), palladin-transfected (F and F=), and palladinFPAA-transfected (G, G=, and G) HeLa cells. Higher magniﬁcations in
panels E= and F= (boxed regions of E and F, respectively) show the highly dendritic actin ﬁlament meshwork, whereas
comet tails in palladinFPAA-expressing cells consist largely of parallel arrays of actin (G= and G). Open arrowheads
indicates bacteria, while solid arrowheads point to the comet tails of interest. Scale bars indicate 1 m in panel G, 500 nm
in panels E and F, and 100 nm in insets.
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FIG 3 Palladin compensates for Arp2/3 complex functional defects during the intracellular motility of L. monocytogenes. (A) Still
frames from movies of HeLa cells transfected with mKate-LifeAct alone to visualize actin or cotransfected with mKate-LifeAct and
GFP-tagged wild-type palladin, palladinK15/18/51A, or palladinFPAA constructs and infected with wild-type L. monocytogenes for at
least 8 h. Bacterial movement halts immediately and comet tails disintegrate following perfusion of CK-666 (100 M) in cells with
endogenous levels of palladin. Bacterial movement and comet tails are unaffected in cells overexpressing palladin variants in the
presence of CK-666 (100 M). Open arrowheads indicate individual bacteria. Elapsed time is shown in minutes and seconds. Scale bar,
5 m. (B and C) The effect of CK-666 (100 M) on the instantaneous (B) and average (C) speeds of L. monocytogenes in cells with
endogenous levels of palladin (red) or overexpressing GFP-tagged wild-type palladin (blue), palladinK15/18/51A (yellow), or pallad-
inFPAA (purple) constructs. The origin of the axes indicates the ﬁnal motility rate measured prior to injection of CK-666 in panel B.
Injection of CK-666 signiﬁcantly decreases bacterial motility rates, except in cells overexpressing wild-type palladin. The mean speed
rates (C) of intracellular L. monocytogenes pre-CK-666 injection and post-CK-666 injection are as follows: 8.990 and 0.279 m/min in
mKate-LifeAct-expressing cells, 7.989 and 8.409 m/min in wild-type palladin-expressing cells, 6.946 and 4.175 m/min in
palladinK15/18/51A-expressing cells, and 1.177 and 0.566 m/min in palladinFPAA-expressing cells. **, P  0.001; *, P  0.01.
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empty vector and allowed the infection to proceed for 16 h, ultimately resulting in the
cell-to-cell spread of bacteria into Arpc2/ cells. As expected, bacteria within Arpc2/
cells expressing GFP alone were unable to generate F-actin at their surface and formed
intracellular clusters (Fig. 4A). However, when Arpc2/ cells overexpressed GFP-
palladin, L. monocytogenes generated actin-rich comet tails enriched with palladin
(Fig. 4A), as was the case with wild-type cells expressing GFP-palladin (Fig. 4A).
To deﬁnitively establish that palladin can induce F-actin nucleation around bacteria
as well as promote the formation and elongation of actin-rich comet tails in the
absence of the Arp2/3 complex, we modiﬁed a previously developed cell-free protein
reconstitution assay (24). This assay allows for the generation of actin clouds and comet
tails in a cell-free system when the bacteria are mixed together with puriﬁed compo-
nents of the actin polymerization machinery that include the Arp2/3 complex, proﬁlin,
coﬁlin, gelsolin, and F-actin. As expected, we were able to generate actin clouds and
comet tails when the protein constituents contained all of the aforementioned com-
ponents (Fig. 4B). To test if puriﬁed palladin could functionally replace the Arp2/3
complex, we substituted palladin for the Arp2/3 complex. We found that full-length
palladin was capable of nucleating F-actin clouds around L. monocytogenes and could
polymerize comet tails behind the bacteria (Fig. 4B). We also identiﬁed long thin
palladin-generated comet tails tethered to clumps of actin (see Fig. S5 at https://
ﬁgshare.com/s/518f2e2e0875d22da012). None of these structures were generated
when the actin-binding domain of palladin (Ig3-palladin) was used in place of full-
length palladin (Fig. 4B). When a palladin variant mutated in its VASP-binding region
(palladinFPAA) was used in place of the wild-type full-length form, actin clouds and
comet tails associated with the bacteria failed to form (see Fig. S6 at https://ﬁgshare
.com/s/dc0aeaf2a28ebc7f1508). However, this mutant form of palladin did produce two
populations of F-actin arrays, linear F-actin bundles and disorganized F-actin clumps
(see Fig. S6), that were reminiscent of the structures generated in cells overexpressing
palladinFPAA (Fig. 2B).
L. monocytogenes ActA augments the polymerization activity of the Arp2/3 complex
(4). Similarly, in vitro actin polymerization rates of reaction mixtures containing both
Arp2/3 and ActA are enhanced compared to reactions using Arp2/3 alone (4). Using
pyrene-actin polymerization assays, we found that ActA also enhanced palladin’s ability
to nucleate and polymerize actin (Fig. 4C).
DISCUSSION
In summary, we have described several novel ways that palladin inﬂuences actin-
rich structures generated during L. monocytogenes infections. When palladin is de-
pleted from cells, comet tails have a tortuous morphology and a diminished length.
When speciﬁc amino acids are altered, comet tails crumble and actin organization
switches from branched networks to parallel arrays. Moreover, we show that palladin
can functionally replace the Arp2/3 complex in infected cells as well as in a cell-free
system by promoting the actin-based motility of the bacteria. How does this protein
mechanistically accomplish this?
The mutation of three lysine amino acids (from K15, K18, and K51 to A) in the Ig3
domain of palladin that causes crumbling comet tails has previously been shown to
severely inﬂuence the cross-linking function of the protein, diminishing it to back-
ground levels (16). Biochemical evidence has demonstrated that when bound to actin,
palladin can also dimerize, which facilitates its cross-linking activity (25). Thus, we
postulate that crumbling comet tails may arise due to the diminished ability of palladin
to bind actin. In turn, this would lower palladin’s ability to dimerize and thus cross-link
actin ﬁlaments within the comet tail dendritic meshwork despite the known presence
of other potent actin cross-linkers, such as -actinin and fascin, at the comet tails (26,
27).
Although palladin is crucial for proper comet tail formation, whether its activity is
also important during listeriopod formation will require further study. We show that
palladin is shed from the actin of the listeriopods, suggesting that it likely has no role
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FIG 4 Palladin generates L. monocytogenes actin-rich clouds and comet tails in the absence of the Arp2/3 complex. (A)
Wild-type and Arpc2/ cells transfected with GFP-palladin or GFP were infected with L. monocytogenes and then ﬁxed and
stained with a rabbit polyclonal antibody targeting p34 (blue) to visualize the Arp2/3 complex and Alexa 350-phalloidin (red)
to visualize actin. The top row shows wild-type cells containing intracellular bacteria with actin comet tails enriched with
palladin and p34. The second row shows cells depleted of the Arp2/3 complex containing intracellular bacteria with actin
comet tails enriched with palladin. The third row shows wild-type cells containing intracellular bacteria with actin comet tails
enriched with p34 but not GFP. The bottom row shows cells depleted of the Arp2/3 complex containing clustered intracellular
bacteria without F-actin at their surface. Open arrowheads within insets (enlargement of boxed regions) indicate individual
intracellular bacteria with actin comet tails, while solid arrowheads point to additional intracellular bacteria with actin comet
tails. Scale bars, 10 m and 2 m (insets). (B) Typical phase-contrast and ﬂuorescent images of actin clouds and comet tails
formed in reaction mixtures containing Arp2/3 (top), full-length palladin (middle), or palladin-Ig3 (bottom). Actin clouds and
comet tails can be generated by either Arp2/3 or palladin but not the actin-binding domain of palladin. Open arrowheads
indicate bacteria, while solid arrowheads point to actin clouds or comet tails. Scale bar, 2 m. (C) Actin polymerization induced
by full-length palladin, Arp2/3, and ActA. Spontaneous assembly reactions were performed by simultaneous addition of actin
(Continued on next page)
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in bacterial cell-to-cell spreading events. The altered distribution of actin-associated
proteins that are present in comet tails but are eliminated from listeriopods has also
been reported for -actinin (28). Interestingly other proteins work in the reverse
manner; being recruited to listeriopods, but not comet tails (28, 29). The differences in
actin-associated components are likely due to the morphological organization of the
actin ﬁlaments within the structures as comet tails contain branched actin arrays and
despite Arp2/3 being present at the bacterial actin interface within listeriopods, the
majority of actin within those protrusions is organized in a parallel arrangement
through formins (28–30).
The role of VASP during L. monocytogenes infections has been studied extensively at
the bacterial surface where it directly binds to ActA and regulates L. monocytogenes
motility rates (18, 31). However, VASP also localizes within the comet tail, and here we
show that an absence of VASP from comet tails in palladinFPAA-expressing cells
dramatically inﬂuences the organization of actin ﬁlaments, changing them from
branched to parallel arrays. In addition to the altered organization of F-actin within the
comet tails, this mutant form of palladin also dramatically alters the cytoskeleton of the
host cell itself as it generates actin-rich cytoplasmic clumps within the cell. Similar
clumps were also generated in the cell-free reconstitution assays when palladinFPAA
was used in place of wild-type palladin, suggesting that either the lack of the VASP
binding domain itself (together with actin) or unknown interactions of the other
components in the assays with this palladin mutant are responsible for the observed
clumping phenotype. Others have found that the absence of VASP from actin-rich
structures increases F-actin branching (32), which may be inﬂuencing the observed
actin clumps. This would be counterintuitive to our observation of “parallel” structures
within the palladinFPAA comet tails. However, in those comet tails VASP remains at the
bacterial surface while absent from the length of the comet tail. At the bacterial surface,
VASP could function by regulating the elongation of the actin ﬁlaments by binding to
barbed ﬁlament ends associated with the bacterial surface in a process dependent on
binding palladin.
Our most signiﬁcant discovery was the demonstration that palladin can functionally
replace the Arp2/3 complex—likely through its ability to nucleate and polymerize
F-actin into actin clouds and motile comet tails. We also showed that ActA further
enhanced palladin’s actin-nucleating activity, but to a much lesser extent than that
generated by the Arp2/3 complex. The substantial disparity between Arp2/3 and
palladin plus ActA nucleation/polymerization activities suggests that another mecha-
nism could be involved during the generation of palladin-mediated actin comet tails.
In addition to its known actin-nucleating and cross-linking roles, palladin is efﬁcient at
stabilizing actin ﬁlaments (15). Palladin also dimerizes upon actin binding (25), and this
could further enhance both ﬁlament cross-linking and stabilization while also providing
additional nucleation sites for actin. Thus, as an alternative strategy, palladin may use
those properties to enhance its nucleating abilities at L. monocytogenes actin-rich
structures.
Because palladin and the Arp2/3 complex are abundant proteins in essentially all
epithelial cells, it remains unclear to what extent the replacement of the Arp2/3
complex with palladin would actually occur during in vivo infections. Our evidence that
palladin itself can nucleate and extend F-actin networks in the complete absence of the
Arp2/3 complex is different from what has been shown previously with -actinin and
fascin as these proteins can only extend actin networks generated by the Arp2/3
complex but not nucleate them (27). Because palladin levels are highly elevated at the
motile leading edge of normal (10) and wounded cells (33–35), as well as the fact that
FIG 4 Legend (Continued)
(5% pyrene labeled, primed with 1 mM EGTA and 0.1 mM MgCl2), palladin (10 M), Arp2/3 (0.37 M), and ActA (0.3 M) as
indicated. Polymerization was monitored by measuring an increase in ﬂuorescence intensity of pyrene actin in the following
reactions: actin alone (gray dashed line), actin with Arp2/3 (gray solid line), actin with palladin (black dashed line), and actin
with both palladin and ActA (black solid line).
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palladin is highly upregulated in motile cancer cells (36–39), we propose a bona ﬁde
cellular function for the actin nucleation role of palladin in enhancing actin-based
motility events within the cell. Overall, these ﬁndings could have broad implications for
an array of cell biology (33, 40), tumor biology (36–39, 41), and microbial pathogenesis
(42) ﬁelds.
MATERIALS AND METHODS
Cell culture. Human cervical (HeLa) and Potorous tridactylus kidney (Ptk2) epithelial cells were
obtained from the American Type Culture Collection (ATCC) (no. CCL-2 and CCL-56, respectively). HeLa
cells were cultured in high-glucose Dulbecco’s modiﬁed Eagle’s medium (DMEM; Hyclone, GE Healthcare)
and were supplemented with 10% fetal bovine serum (FBS; Gibco, Thermo Fisher Scientiﬁc). Ptk2 cells
were cultured in 1:1 DMEM–F-12 (Hyclone, GE Healthcare) supplemented with 10% FBS. Both cell lines
were maintained in a cell culture incubator (37°C, 5% CO2). To obtain Arpc2/ cells, the parental mouse
embryonic ﬁbroblast (MEF) cell line designated 10-4 was treated with puromycin dihydrochloride (Sigma)
and 4-hydroxy-tamoxifen (4-OHT; Sigma), as described previously (23). To seed cells for experiments,
ﬂasks or culture dishes with cells were washed 3 with Dulbecco’s phosphate-buffered saline without
Ca2 and Mg2 (PBS[/]) (Gibco, Thermo Fisher Scientiﬁc), trypsinized with 0.05% trypsin-EDTA (Gibco,
Thermo Fisher Scientiﬁc), and seeded onto clear polystyrene 6-well plates (Corning) containing glass
coverslips. For electron microscopy experiments, ﬂexible silicone elastomer membranes (Flexcell Inter-
national) were used in place of glass coverslips.
Bacterial strains and growth conditions. The bacterial strains used were the L. monocytogenes wild
type EGD BUG 600 and the ΔactA mutant (a gift by Pascale Cossart). All L. monocytogenes strains were
grown at 37°C using either brain heart infusion (BHI) agar or broth (BD Biosciences).
Listeria monocytogenes infections. To infect cultured cells, broth cultures of L. monocytogenes
shaken overnight were diluted 10 in BHI broth and then incubated at 37°C in a shaking incubator until
an A600 of 1.00. Once cultures reached an A600 of 1.00, bacteria were spun down for 5 min at 10,000 rpm
(25°C) and washed with PBS[/]. Pelleted bacteria were resuspended with serum-free medium and
then diluted 100. Diluted bacteria were added onto culture plates containing host cells and incubated
for 30 min to study bacterial internalization or at least 6 h to study comet tails and listeriopod formation.
To infect Arpc2/ cells, wild-type cells were infected for 2 h, collected from culture plates, and overlaid
onto culture plates containing uninfected Arpc2/ cells, where the infection was allowed to proceed for
an additional 14 to 18 h.
Antibodies and reagents. The antibodies used in this study included the following: Alexa Fluor 594-,
488- and 350-conjugated phalloidin from Invitrogen; Alexa Fluor 594-, 488-, and 350-conjugated goat
anti-rabbit and goat anti-mouse antibodies (2 g/ml) from Invitrogen; mouse anti-palladin antibody
(50 g/ml for immunoﬂuorescence and 500 g/ml for Western blotting) from Novus Biologicals, Inc.; rabbit
anti-palladin antibody (0.002 g/ml for immunoﬂuorescence and 0.002 g/ml for Western blotting) from the
Proteintech Group; rabbit anti-VASP antibody (1.1 g/ml for immunoﬂuorescence and 0.1 g/ml for Western
blotting) from Sigma; rabbit anti-p34 antibody (10 g/ml for immunoﬂuorescence) from Millipore; rabbit
anti-actin antibody (0.1 g/ml for Western blotting) from Abcam, Inc.; rabbit anti-calnexin antibody (1:2,000
for Western blotting) from Sigma; and horseradish peroxidase (HRP)-conjugated goat anti-rabbit and goat
anti-mouse antibodies (1 g/ml) from Invitrogen. The reagents used in this study included the following:
puriﬁed proﬁlin, coﬁlin, gelsolin, Arp2/3 complex, rhodamine-actin, skeletal actin, and ATP from Cytoskeleton,
Inc.; methylcellulose CP4000 and 1,4-diazabicyclo[2.2.2]octane (DABCO) from Sigma; dithiothreitol (DTT) from
Sigma-Roche; and CK-666 (100 M) from Abcam, Inc.
Immunolocalization. For immunoﬂuorescence studies, cells were ﬁxed at room temperature for
15 min using prewarmed (37°C) 3% paraformaldehyde (prepared in 150 mM NaCl, 4 mM Na/KPO4,
5.0 mM KCl [pH 7.3]) and then washed 3 with PBS[/]. Cells were permeabilized with room
temperature 0.1% Triton X-100 (prepared in PBS[/]) for 5 min and then washed 3 with PBS[/].
Samples treated with mouse anti-palladin antibodies required permeabilization with 20°C acetone for
10 min followed by air drying at room temperature for 30 min. All samples were then blocked with 5%
normal goat serum (prepared in PBS[/]) for 20 min, after which samples were incubated overnight at
4°C with primary antibodies prepared in TPBS/BSA (PBS[/], 0.5% Tween 20, 0.1% bovine serum
albumin [BSA]). Following this, samples were washed 3 with TPBS/BSA for 10 min and then treated with
secondary antibodies (Alexa Fluor 594- or 488-conjugated goat anti-rabbit or goat anti-mouse antibod-
ies) at room temperature for 2 h. To visualize F-actin, samples were incubated with Alexa Fluor 594-, 488-,
or 350-conjugated phalloidin (prepared in PBS[/]) for 20 min. Samples were washed 3 with
PBS[/] and mounted onto glass microscope slides using Prolong Diamond antifade mountant
containing DAPI (4=,6-diamidino-2-phenylindole; Invitrogen).
Lysate preparation and Western blotting. Lysates were prepared by washing the samples 3 with
prewarmed PBS[/] and then treating the samples with ice-chilled radioimmunoprecipitation assay
(RIPA) lysis buffer (150 mM NaCl, 50 mM Tris [pH 7.4], 5 mM EDTA, 1% Nonidet P-40, 1% deoxycholic acid,
10% SDS) with cOmplete Mini EDTA-free protease inhibitor cocktail (Roche) on ice for 5 min. Cells were
disrupted using cell scrapers, and lysates were collected into microcentrifuge tubes. Lysates were spun
at 4°C and 10,000  g for 10 min to pellet cellular debris; supernatants were collected into fresh
microcentrifuge tubes and immediately stored at 80°C. Protein concentrations were determined using
a bicinchoninic acid (BCA) assay kit (Pierce). For Western blotting, lysate samples were ﬁrst prepared in
6 Laemmli buffer and then boiled for 10 min. Equal amounts of protein were loaded onto 10%
SDS–polyacrylamide gels and subsequently resolved by electrophoresis. Following separation, gels were
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rinsed in water for 5 min and then transferred onto nitrocellulose membranes using a Trans-Blot SD
semidry transfer cell (Bio-Rad). After the transfer, the membranes were washed for 5 min in TBST
(Tris-buffered saline, 0.05% Tween 20), blocked with 4% Blotto (Santa Cruz Biotechnology) prepared in
TBST, and then treated with primary antibodies (diluted in TBST plus 1% BSA) overnight at 4°C.
Membranes were washed 3 with TBST for 10 min each prior to incubation with secondary antibodies
(HRP-conjugated goat anti-rabbit or goat anti-mouse antibodies) for 1 h at room temperature. Mem-
branes were treated with Western Lightning Plus-ECL (PerkinElmer) following the manufacturer’s instruc-
tions and visualized using a Fujiﬁlm LAS-4000 imager (Fujiﬁlm). To conﬁrm equal loading, membranes
were stripped of bound antibodies with mild stripping buffer (1.5% glycine, 0.1% SDS, 1% Tween 20
[pH 2.2]) and reprobed using antibodies targeting actin or calnexin as outlined above.
DNA constructs. All palladin constructs used consisted of the major 90-kDa isoform, commonly
referred to as isoform 4. These included GFP vectors containing wild-type palladin and the actin-binding
mutant GFP-palladinK15/18/51A. GFP-palladinFPAA, the VASP-binding mutant construct, was generated
from the phrGFPIIN-palladin (human isoform 4) construct. For vector controls, the phrGFPIIN vector
(Stratagene) was utilized. The phenylalanine and proline residues found in the polyproline region of
palladin were both mutated to alanine using site-directed mutagenesis with the following primers:
5=-GTGCCCGACGTGGCCGCACTGCCGCCGCCACCA-3= and 5=-TGGTGGCGGCGGCAGTGCGGCCACGTCGGG
CAC-3=. Plasmids containing mKate-LifeAct or enhanced green ﬂuorescent protein (eGFP)-LifeAct were a
gift from Michael Davidson (Addgene plasmid no. 54697 and 54610, respectively).
Microscopy and live-cell imaging. Images were acquired using a Leica DMI4000B (Leica Microsys-
tems, Inc.) inverted ﬂuorescence microscope ﬁtted with a Hamamatsu Orca R2 charge-coupled device
(CCD) camera (Hamamatsu Photonics). All devices were controlled by MetaMorph Imaging System
software (Universal Imaging). The images obtained were evaluated using Metamorph Imaging System
software or ImageJ. For live-cell imaging, a Chamlide IC top-stage incubator system was used to maintain
a constant temperature and environment of 37°C and 5% humidiﬁed CO2 gas in air. Bacterial motility
rates and comet tails were analyzed using ImageJ. For CK-666 studies, DMEM (without phenol red) plus
10% FBS containing 100 M CK-666 (prepared in dimethyl sulfoxide [DMSO]) was perfused into magnetic
coverslip-containing chambers (Chamlide) during the infections at the indicated times.
Cell culture transfections. All DNA transfections of cultured cells were performed using jetPEI or
jetPRIME transfection reagents (Polyplus Transfection) and were carried out according to the manufac-
turer’s instructions. Brieﬂy, cells were transfected and allowed to incubate at 37°C for 4 h. Following this,
medium was replaced and cells were incubated for 24 h at 37°C to allow the expression of the respective
gene product. Transfected cells were either ﬁxed for viewing by immunoﬂuorescence microscopy or
imaged live by time-lapse microscopy.
Palladin RNAi knockdown. For RNA interference (RNAi) knockdown, a smart pool (ON-Targetplus
siRNA) of 4 palladin siRNAs and 4 nontargeting control siRNAs was purchased from Dharmacon (GE
Healthcare). Transfections were performed using the siRNA transfection reagent INTERFERin (Polyplus
transfection) following the manufacturer’s instructions. Brieﬂy, 0.1 ml of serum-free medium containing
50 nM siRNA duplexes and INTERFERin was added to cells contained in clear polystyrene 24-well culture
plates. To obtain cells with undetectable levels of palladin protein, cells required a 72-h incubation period
following the siRNA treatment.
Electron microscopy. Medium was replaced with ﬁxative (1.5% paraformaldehyde, 1.5% glutaral-
dehyde, and 0.1 M sodium cacodylate [pH 7.3] at room temperature) and left for 2 to 3 h, and then the
ﬁxative was replaced with buffer (0.1 M sodium cacodylate [pH 7.3], room temperature). The membranes,
with attached cells, were gently cut away from cell culture dishes and then further cut into 1- to 2-cm2
pieces. The pieces were placed in glass vials and then washed twice (10 min each wash) with fresh buffer.
The samples were postﬁxed for 1 h on ice with 1% osmium tetroxide in 0.1 M sodium cacodylate (pH 7.3).
The samples were washed three times (10 min each wash) with ddH2O (room temperature) and then
stained en bloc with 1% aqueous uranyl acetate (room temperature). The membranes were again
washed three times with double-distilled water (ddH2O; room temperature) and then dehydrated
through an ascending series of ethyl alcohols (30%, 50%, 70%, 95%, 2  100% for 10 min each) followed
by two treatments with propylene oxide (15 min each). The samples were then placed in 1:1 mixture of
propylene oxide and Embed 812 resin (Electron Microscopy Sciences, Hatﬁeld, PA) and left overnight. The
following day, the membranes were passed through two changes of 100% Embed 812 resin and then
placed on glass slides with the cells faceup. Embedding capsules were ﬁlled with resin and inverted onto
the membranes, and then the slides with membranes and embedding capsules were placed in an oven
(60°C) for the resin to polymerize for 48 h. After polymerization, the capsules (with embedded cells) were
carefully separated from the membranes that remained attached to the slides. The cell layers at the
surfaces of the block were sectioned en face using a Leica ultramicrotome and collected onto copper
grids. The sections were stained with uranyl acetate and lead citrate and then viewed, and images were
collected using an FEI Tecnai G2 Spirit electron microscope operated at 120 kV.
Protein puriﬁcation. Full-length 90-kDa human palladin was subcloned into the pTBSG expression
vector to allow for expression of a His6 fusion protein. The construct was transformed into Escherichia coli
BL21(DE3) cells (NEB, Ipswich, MA), and cells were grown at 37°C until the optical density at 600 nm
(OD600) reached 0.6 in ZYM-5052 autoinduction media. Cell cultures were pelleted down and resus-
pended in lysis buffer (20 mM sodium phosphate, 300 mM NaCl, 2 mM DTT, 10% glycerol [pH 7.4]),
followed by sonication and clearing of cell lysate by centrifugation. Supernatant was incubated with
ProteIndex Ni-Penta agarose 6 Fast Flow (Marvelgent Biosciences, Inc., Canton, MA) slurry overnight at
4°C before the protein was puriﬁed according to the manufacturer’s guidelines. The elution fraction was
dialyzed into S-column buffer A (25 mM KH2PO4, 50 mM NaCl, 2 mM DTT [pH 6.5]) before being loaded
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onto a cation-exchange column on an Äkta fast protein liquid chromatography (FPLC) device (GE
Healthcare) with a HiPrep SP XL column. The protein was eluted using a gradient with a target of 100%
buffer B (25 mM KH2PO4, 1 M NaCl, 2 mM DTT [pH 6.5]). Fractions containing palladin were conﬁrmed
by SDS-PAGE, and protein was dialyzed into storage buffer containing 20 mM HEPES, 150 mM NaCl
(pH 7.5), and 2 mM tris(2-carboxyethyl)phosphine (TCEP). Puriﬁcation of L. monocytogenes ActA-His
(strain DPL1545) was performed as previously described (4). The Arp2/3 protein complex was purchased
from Cytoskeleton, Inc. Actin was puriﬁed from rabbit muscle acetone powder (PelFreez Biologicals) by
the method of Spudich and Watt (43) and gel ﬁltered on a 16/60 Sephacryl S-200 column (GE Healthcare
Life Sciences). Puriﬁed monomeric actin was stored at 4°C in G-buffer (5 mM Tris [pH 8], 0.1 mM CaCl2,
0.2 mM DTT, 0.2 mM ATP, 0.02% sodium azide) and used within 2 to 4 weeks. Pyrene-labeled actin was
prepared by the reaction of N-(1-pyrenyl) iodoacetamide (Sigma-Aldrich) with gel-ﬁltered monomeric
actin (G-actin) as described previously (44).
Reconstitution of Listeria actin clouds and comet tails using puriﬁed proteins. On the day of the
experiments, fresh stocks of the following were prepared: assay buffer (10 mM HEPES [pH 7.5], 0.1 M KCl,
1 mM MgCl2, 0.1 mM CaCl2, 1 mM ATP), ATP–1,4-diazabicyclo[2.2.2]octane (DABCO)–DTT (ADD) mixture
(made by mixing together 20 l of 30 mM ATP/60 mM MgCl2, 10 l 2.2 mM DABCO, and 5 l 0.2 M DTT),
1% methylcellulose CP4000, 10% BSA, and 48 M Mg–F-actin. To reconstitute actin polymerization
around L. monocytogenes (BUG 600), the following reagents were added in order to an Eppendorf tube
(at the following ﬁnal concentrations) to create the reaction mixture: 0.5% BSA, 3.7 M coﬁlin, 2.5 M
proﬁlin, 50 nM gelsolin, 75 nM Arp2/3 or 4.875 M palladin (full-length, Ig3-palladin, or palladinFPAA),
3.0 l ADD/24-l reaction mixture, 1 M rhodamine–G-actin, 2  108 L. monocytogenes cells/ml in assay
buffer, 7.6 M Mg–F-actin, and 0.23% methylcellulose. Anywhere from 2 to 5 l of the reaction mixture
was spotted onto a 35-mm Fluorodish (WPI, Inc.) or standard glass microscope slide premarked with a
DakoCytomation pen and then covered with a 12-mm glass circle coverslip. Coverslips were added
carefully so as to not squish down against the droplet. Samples were then placed onto the microscope
to begin phase-contrast as well as ﬂuorescence microscopy observation of actin cloud and comet tail
formation.
Pyrene ﬂuorescence assay. Pyrenyl actin and unlabeled G-actin were mixed together to make 5 M
5% pyrene-labeled G-actin stock. Labeled G-actin (100 l) was incubated with (10 l) of 10 priming
solution (10 mM EGTA, 1 mM MgCl2) for 2 min, and then polymerization was induced by adding 0.37 M
Arp2/3 and 10 M full-length palladin with or without 0.3 M ActA. All reactions were performed in
G-buffer (without KCl). Pyrene ﬂuorescence was measured immediately with excitation at 365 nm and
emission at 385 nm on a PTI ﬂuorescence spectrometer.
Statistical analysis. Statistical analysis was performed with Student’s unpaired t test (Mann-Whitney
U test for nonparametric tests) or 1-way analysis of variance (ANOVA) with the Tukey post hoc test when
comparing means of two or more groups in GraphPad Prism version 6.01. All data are presented as bar
graphs with mean  standard error of the mean (SEM) unless indicated otherwise. Experiments were
performed at least 3 times (n  3), and the person who performed the experiment performed all of the
enumeration and statistical analyses. All data involving immunoﬂuorescence microscopy were obtained
from experiments performed at least 3 times (n  3). The presented microscopy images are represen-
tative of experiments performed. In Fig. 1C, at least 45 comet tails were measured per condition per
experiment (230 and 162 comet tails in total were measured in control and knockdown cells, respec-
tively). In Fig. 1D, at least 45 comet tails were measured per condition per experiment (116 and 110
comet tails in total were measured in control and knockdown cells, respectively). Data in Fig. 1C depict
average values (standard deviation) from 3 independent experiments, with the 99% conﬁdence interval
indicated by an asterisk. Data in Fig. 1D depict average values (standard error) from 3 independent
experiments, with the 99% conﬁdence interval indicated by an asterisk. In Fig. 2C, data show average
values (standard error) from at least 10 rate measurements, which were performed per group over the
course of 3 independent experiments, with 99% conﬁdence intervals indicated by asterisks. For Fig. 3B,
the instantaneous speeds of 19, 16, 13, and 4 bacteria in cells expressing mKate-LifeAct, mKate-LifeAct
and GFP-palladin, mKate-LifeAct and GFP-palladinK15/18/51A, or mKate-LifeAct and GFP-palladinFPAA,
respectively, were measured with the total time of bacteria being measured ranging from a minimum of
approximately 5 min up to approximately 10 min. For Fig. 3C, data show average values (standard
error), with 90% and 99% conﬁdence intervals indicated by asterisks.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/mBio
.02259-17.
MOVIE S1, AVI ﬁle, 0.9 MB.
MOVIE S2, AVI ﬁle, 5.4 MB.
MOVIE S3, AVI ﬁle, 0.8 MB.
MOVIE S4, AVI ﬁle, 1.4 MB.
MOVIE S5, AVI ﬁle, 1.5 MB.
MOVIE S6, AVI ﬁle, 1.7 MB.
MOVIE S7, AVI ﬁle, 0.3 MB.
MOVIE S8, AVI ﬁle, 1.5 MB.
MOVIE S9, AVI ﬁle, 1.2 MB.
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